{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:31:27Z","timestamp":1788093087810,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.lungcan.2023.107454","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T21:37:02Z","timestamp":1703799422000},"page":"107454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Laura","family":"Burns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Tukachinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Raskina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.P.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Kulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Oxnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-3004","authenticated-orcid":false,"given":"Umit","family":"Tapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lungcan.2023.107454_b0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1067\/mtc.2002.122523","article-title":"Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases","volume":"124","author":"Takei","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.lungcan.2023.107454_b0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-199106000-00003","article-title":"Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases","volume":"15","author":"Travis","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.lungcan.2023.107454_b0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1183\/09031936.01.00275301","article-title":"The new World Health Organization classification of lung tumours","volume":"18","author":"Brambilla","year":"2001","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.lungcan.2023.107454_b0025","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.cllc.2016.01.003","article-title":"Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes","volume":"17","author":"Naidoo","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1078-0432.CCR-16-0355","article-title":"Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung","volume":"23","author":"Miyoshi","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107454_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment OutcomeChemotherapy Outcome in LCNEC Is Predicted by RB1 Status","volume":"24","author":"Derks","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2023.107454_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.653153","article-title":"Prevalence of TP-53\/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma","volume":"11","author":"Saghaeiannejad Esfahani","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107454_b0045","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.lungcan.2023.107454_b0050","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma\u2013like and Non-Small Cell Carcinoma\u2013like SubsetsLarge Cell Neuroendocrine Carcinoma Genomics","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2023.107454_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00150","article-title":"Large-Cell Neuroendocrine Carcinoma of the Lung: A Focused Analysis of BRAF Alterations and Case Report of a BRAF Non-V600\u2013Mutated Tumor Responding to Targeted Therapy","volume":"2","author":"Chae","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2023.107454_b0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2169\/internalmedicine.9368-17","article-title":"Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib","volume":"57","author":"Hayashi","year":"2018","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.lungcan.2023.107454_b0065","doi-asserted-by":"crossref","first-page":"e0817","DOI":"10.1002\/rcr2.817","article-title":"Dramatic response to alectinib in an ALK-positive LCNEC patient with a poor performance status: A case report","volume":"9","author":"Masuda","year":"2021","journal-title":"Respirol Case Rep"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0070","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1159\/000511112","article-title":"Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report","volume":"13","author":"Muto","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.lungcan.2023.107454_b0075","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.2147\/OTT.S172124","article-title":"ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature","volume":"11","author":"Zheng","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.21037\/tlcr.2020.02.13","article-title":"Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis","volume":"9","author":"Baine","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.lungcan.2023.107454_b0085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0090","doi-asserted-by":"crossref","first-page":"e0264138","DOI":"10.1371\/journal.pone.0264138","article-title":"Clinical and analytical validation of FoundationOne\u00aeCDx, a comprehensive genomic profiling assay for solid tumors","volume":"17","author":"Milbury","year":"2022","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lungcan.2023.107454_b0095","doi-asserted-by":"crossref","first-page":"e0237802","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2023.107454_b0100","doi-asserted-by":"crossref","first-page":"e2200261","DOI":"10.1200\/PO.22.00261","article-title":"Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples","volume":"6","author":"Husain","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107454_b0105","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","article-title":"Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids","volume":"10","author":"Alcala","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107454_b0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2005.04.1202","article-title":"Neuroendocrine neoplasms of the lung: a prognostic spectrum","volume":"24","author":"Asamura","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2023.107454_b0115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.athoracsur.2007.03.093","article-title":"Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma","volume":"84","author":"Iyoda","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.lungcan.2023.107454_b0120","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.cllc.2019.07.011","article-title":"Large-cell neuroendocrine carcinoma of the lung: a population-based study","volume":"21","author":"Kinslow","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2023.107454_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650293","article-title":"Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities","volume":"11","author":"Ferrara","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.lungcan.2023.107454_b0130","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01838-2016","article-title":"Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?","volume":"49","author":"Derks","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107454_b0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.lungcan.2023.107454_b0140","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2559.2010.03486.x","article-title":"Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability","volume":"56","author":"den Bakker","year":"2010","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107454_b0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0046-8177(98)90047-8","article-title":"Reproducibility of neuroendocrine lung tumor classification","volume":"29","author":"Travis","year":"1998","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.lungcan.2023.107454_b0155","doi-asserted-by":"crossref","first-page":"e73484","DOI":"10.1371\/journal.pone.0073484","article-title":"Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts","volume":"8","author":"Suzuki","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lungcan.2023.107454_b0160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.lungcan.2023.107454_b0165","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223009923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500223009923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:05:17Z","timestamp":1759237517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500223009923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":33,"alternative-id":["S0169500223009923"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107454","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107454"}}